Medical Innovation for Bone and Cartilage
Link Pharma is a leading Biotech company addressing high unmet medical needs in the field of cartilage and orthopaedics diseases.
We have a broad, diversified portfolio of disease modifying solutions in clinical development across a number of important age related orthopaedics diseases with large unmet medical needs but limited therapeutic breakthroughs.
Our major clinical focus is DMOAD, a category of disease modifying OA drugs.
Our technology is based on our proprietary approaches and know-how to access cartilage regeneration by MRI and application of biomarker to correlate with the response. BioBone is also conducting research on next generation products such as Drug-Device Combo and cell-matrix products for complicated bone defects and spinal applications.
OA is a flaring degenerative arthropathy and a chronic disorder which can potentially affect all synovial joints. The incidence and the disability rate of OA is high and the social burden is great.
Now there are no effective drugs to improve the joints’ structure and the clinical gap is great.
DMOAD are these drugs have an effect on the progression of the pathological changes in OA and show beneficial impact on structural progression in OA. It is proposed relative to the current symptom modifying drugs for treatment OA.
Global OA patients
> 400 million
The market value of DMOAD
15-25 billion USD
USING MRI TO EVALUATE THE STRUCTURAL IMPROVEMENT
Having unique and world-leading MRI evaluation system to access cartilage regeneration, we have know how based on 100,000 cases.
INVENTIONS ON BIOMARKER FOR PARENTS GROUPING
Having proprietary approaches and know how to identify OA related biomarker and establish a system for developing orthopaedics precision medication.
KNOW HOW ON DIVERSIFIED COMBO
A range of DMOAD candidates in development and the complex orthopaedics diseases can be solved by drug-device Combo.
Our passion for creating meaningful change for clients is what sets us apart. The Link Pharma team believes in the potential of our great idea, and it truly shows in all of our work. We work tirelessly in order to bring you a better tomorrow, and we’re proud of every single member of staff. To learn more about the incredible Link Pharma team, please have a look below.
CHRIS LADEL, PHD